Next Generation MarginProbe
Real-time margin assessment in breast cancer surgery
DevelopmentActive
Key Facts
Indication
Real-time margin assessment in breast cancer surgery
Phase
Development
Status
Active
Company
About Dilon Technologies
Dilon Technologies is a commercial-stage medical device company with a 20+ year history, operating in over 76 countries. Its core business revolves around a portfolio of surgical technologies, including the MarginProbe system for intraoperative breast cancer margin assessment and HEMOBLAST Bellows for hemostasis. The company positions itself at the intersection of women's health and biosurgery, leveraging a direct commercialization model to serve healthcare providers globally. Its strategy involves both enhancing its established products and developing next-generation iterations.
View full company profile